99 related articles for article (PubMed ID: 2938091)
1. [Treatment of septicemia and endocarditis with pefloxacine. 15 cases].
Wolff M; Pangon B; Regnier B; Rouveix E; Bauchet J; Vachon F
Presse Med; 1986 Mar; 15(10):471-4. PubMed ID: 2938091
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Thauvin C; Lemeland JF; Humbert G; Fillastre JP
Antimicrob Agents Chemother; 1988 Jun; 32(6):919-21. PubMed ID: 3166360
[TBL] [Abstract][Full Text] [Related]
3. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
[TBL] [Abstract][Full Text] [Related]
4. [Salvage treatment of multi-resistant pulmonary tuberculosis. Efficacy of pefloxacine].
Fur A; Massin F; Camus P; Waldner A; Jeannin L
Presse Med; 1987 Jan; 16(3):128. PubMed ID: 2950436
[No Abstract] [Full Text] [Related]
5. [Intracameral penetration of pefloxacine in man].
Bron A; Talon D; Delbosc B; Estavoyer JM; Prost F; Montard M
J Fr Ophtalmol; 1986; 9(4):317-21. PubMed ID: 3495563
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
Denis F; Mounier M; Lagarde C; Benevent D
Pathol Biol (Paris); 1987 May; 35(5):652-5. PubMed ID: 3302879
[TBL] [Abstract][Full Text] [Related]
7. [Pefloxacine and severe eye infections].
Massin-Cochereau I; Le Hoang P; Weiser M; Rousselie F
Bull Soc Ophtalmol Fr; 1987; 87(6-7):735-6, 738. PubMed ID: 3499243
[No Abstract] [Full Text] [Related]
8. Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
Contrepois A; Daldoss C; Pangon B; Garaud JJ; Kecir M; Sarrazin C; Vallois JM; Carbon C
J Antimicrob Chemother; 1984 Jul; 14(1):51-7. PubMed ID: 6384175
[TBL] [Abstract][Full Text] [Related]
9. [Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
Fourrier F; Chopin C; Lestavel P; Savage C
Presse Med; 1986 Jun; 15(26):1240. PubMed ID: 2944094
[No Abstract] [Full Text] [Related]
10. [Tolerance to pefloxacine during treatment of a series of osteoarticular infections. 36 cases].
Lopitaux R; Hermet R; Sirot J; Filiu P; Terver S
Therapie; 1985; 40(5):349-52. PubMed ID: 3868205
[No Abstract] [Full Text] [Related]
11. Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
Tigaud S; Marcatello A; Gille Y; Robert D; Vincent P
Drugs Exp Clin Res; 1985; 11(3):169-76. PubMed ID: 3869804
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of pefloxacin.
Husson MO; Izard D; Bouillet L; Leclerc H
Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of Morganella morganii meningitis with pefloxacin mesylate.
Isaacs RD; Ellis-Pegler RB
J Antimicrob Chemother; 1987 Nov; 20(5):769-70. PubMed ID: 3480886
[No Abstract] [Full Text] [Related]
14. [Pharmacokinetic study of pefloxacin in 37 hospital patients under resuscitation].
Chomarat M; Joulie V; Fournier G; Bouletreau P; Flandrois JP
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):539-41. PubMed ID: 3911151
[TBL] [Abstract][Full Text] [Related]
15. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Berardi-Grassias LD; Roy O
Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
17. [In-vivo bacteriostatic and bactericidal activity of pefloxacine].
Meyran M; Thabaut A
Pathol Biol (Paris); 1986 May; 34(5):349-52. PubMed ID: 3095772
[TBL] [Abstract][Full Text] [Related]
18. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
[TBL] [Abstract][Full Text] [Related]
19. [Pefloxacin in the treatment of septicemia, purulent meningitis and salmonellosis].
Dordević D; Kaplan M; Cengić D; Vranić B; Dimitrijević K
Med Arh; 1989; 43(4-6):207-10. PubMed ID: 2640275
[TBL] [Abstract][Full Text] [Related]
20. Pefloxacin in acute exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Teengs JP
J Antimicrob Chemother; 1985 Sep; 16(3):379-88. PubMed ID: 3863811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
